Relmada Therapeutics Inc (RLMD)
3.68
-0.04
(-1.08%)
USD |
NASDAQ |
May 03, 16:00
3.66
-0.02
(-0.54%)
After-Hours: 20:00
Relmada Therapeutics Total Return Level: 3.68 for May 3, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 03, 2024 | 3.68 |
May 02, 2024 | 3.72 |
May 01, 2024 | 3.69 |
April 30, 2024 | 3.64 |
April 29, 2024 | 3.53 |
April 26, 2024 | 3.83 |
April 25, 2024 | 3.70 |
April 24, 2024 | 3.86 |
April 23, 2024 | 3.91 |
April 22, 2024 | 3.87 |
April 19, 2024 | 4.00 |
April 18, 2024 | 4.30 |
April 17, 2024 | 4.68 |
April 16, 2024 | 4.56 |
April 15, 2024 | 4.45 |
April 12, 2024 | 4.65 |
April 11, 2024 | 4.66 |
April 10, 2024 | 4.51 |
April 09, 2024 | 4.80 |
April 08, 2024 | 4.86 |
April 05, 2024 | 4.59 |
April 04, 2024 | 4.69 |
April 03, 2024 | 4.71 |
April 02, 2024 | 4.94 |
April 01, 2024 | 4.88 |
Date | Value |
---|---|
March 28, 2024 | 4.65 |
March 27, 2024 | 4.59 |
March 26, 2024 | 4.69 |
March 25, 2024 | 4.90 |
March 22, 2024 | 4.86 |
March 21, 2024 | 4.66 |
March 20, 2024 | 4.435 |
March 19, 2024 | 5.37 |
March 18, 2024 | 5.52 |
March 15, 2024 | 5.42 |
March 14, 2024 | 5.03 |
March 13, 2024 | 5.64 |
March 12, 2024 | 5.53 |
March 11, 2024 | 5.77 |
March 08, 2024 | 6.35 |
March 07, 2024 | 6.37 |
March 06, 2024 | 6.40 |
March 05, 2024 | 6.32 |
March 04, 2024 | 6.35 |
March 01, 2024 | 6.80 |
February 29, 2024 | 6.125 |
February 28, 2024 | 6.14 |
February 27, 2024 | 5.93 |
February 26, 2024 | 5.91 |
February 23, 2024 | 5.68 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
2.17
Minimum
Dec 08 2022
50.12
Maximum
Feb 26 2020
20.78
Average
22.25
Median
Dec 23 2021
Total Return Level Benchmarks
Cyclacel Pharmaceuticals Inc | 2.00 |
Lifecore Biomedical Inc | 6.39 |
Harrow Inc | 10.38 |
Corvus Pharmaceuticals Inc | 1.92 |
Aquestive Therapeutics Inc | 3.52 |